Cost assessment in melanoma clinical trials: A cross-sectional study
JAAD Int
.
2023 May 26:12:139-141.
doi: 10.1016/j.jdin.2023.05.005.
eCollection 2023 Sep.
Authors
Rachel S Goodman
1
,
Desmond C Garner
1
,
Stefan Koester
1
,
J Randall Patrinely Jr
2
,
Anna K Dewan
2
,
Douglas B Johnson
3
Affiliations
1
Vanderbilt University School of Medicine, Nashville, Tennessee.
2
Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee.
3
Department of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
PMID:
37409320
PMCID:
PMC10319333
DOI:
10.1016/j.jdin.2023.05.005
No abstract available
Keywords:
clinical trials; cost; cost effectiveness; melanoma; skin cancer.